dexmedetomidine has been researched along with Hemorrhage, Subarachnoid in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| A, JY; Ding, XS; Ge, WH; Li, YC; Liu, T; Na, SJ; Sun, RB; Wang, R | 1 |
| Han, DW; Han, Y; Lim, BJ; Oh, JE; Song, Y | 1 |
| Frantzén, J; Grönlund, J; Kallioinen, M; Katila, A; Olkkola, KT; Posti, JP; Rahi, M; Saari, TI; Sharma, D; Takala, R; Vahlberg, T | 1 |
| Busl, KM; Doré, S; Liu, H | 1 |
| Chen, CJ; Dunn, LK; Esfahani, K; Lacomis, C; Naik, BI; Zuo, Z | 1 |
| Hifumi, T; Kawakita, K; Kawanishi, M; Kuroda, Y; Miyake, K; Ogawa, D; Okauchi, M; Okazaki, T; Shindo, A; Shishido, H; Tamiya, T | 1 |
| Han, DW; Ju, JW; Kim, DH; Lim, BJ; Song, Y | 1 |
| Gao, W; Guo, Q; Han, L; Li, F; Liu, H; Ma, Y; Sun, D; Wang, Y; Wang, Z; Wu, Y; Xu, X; Yin, D; Zhang, J; Zhou, S | 1 |
| Jena, S; Mittal, M; Reddy, M; Sriganesh, K; Umamaheswara Rao, GS | 1 |
| Banik, S; Prabhakar, H | 1 |
| Reddy, M; Sriganesh, K; Umamaheswara Rao, GS | 1 |
| Han, R; Wang, Y; Zuo, Z | 1 |
| Slosberg, PS | 1 |
| Acikgoz, B; Ayoglu, H; Bahadir, B; Bektas, S; Gul, S; Hanci, V; Mungan, AG; Turan, IO | 1 |
| Drummond, JC; Sturaitis, MK | 1 |
| Kamii, H; Kato, M; Sato, K; Shimizu, H | 1 |
| Buyukbas, S; Cosar, M; Ela, Y; Eser, O; Fidan, H; Ozen, OA; Sahin, O; Yagmurca, M | 1 |
1 review(s) available for dexmedetomidine and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Role of Dexmedetomidine in Aneurysmal Subarachnoid Hemorrhage: A Comprehensive Scoping Review.
Topics: Brain Ischemia; Dexmedetomidine; Humans; Retrospective Studies; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2022 |
2 trial(s) available for dexmedetomidine and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
A comparative study of dexmedetomidine and propofol as sole sedative agents for patients with aneurysmal subarachnoid hemorrhage undergoing diagnostic cerebral angiography.
Topics: Adult; Aged; Cerebral Angiography; Dexmedetomidine; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Middle Aged; Propofol; Prospective Studies; Subarachnoid Hemorrhage | 2015 |
[Preoperative sedation with dexmedetomidine in patients with aneurysmal subarachnoid hemorrhage].
Topics: Adrenergic alpha-Agonists; Adult; Aged; Aged, 80 and over; Anesthesia, General; Conscious Sedation; Dexmedetomidine; Diazepam; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Pentazocine; Preanesthetic Medication; Subarachnoid Hemorrhage | 2006 |
14 other study(ies) available for dexmedetomidine and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Cerebrospinal fluid metabolic profiling reveals divergent modulation of pentose phosphate pathway by midazolam, propofol and dexmedetomidine in patients with subarachnoid hemorrhage: a cohort study.
Topics: Aged; Cohort Studies; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Pentose Phosphate Pathway; Propofol; Psychomotor Agitation; Subarachnoid Hemorrhage | 2022 |
Dexmedetomidine attenuates subarachnoid hemorrhage-induced acute lung injury through regulating autophagy and TLR/NFκB signaling pathway.
Topics: Acute Lung Injury; Animals; Autophagy; Dexmedetomidine; Interleukin-6; Male; NF-kappa B; Pulmonary Edema; Rats; Rats, Wistar; Signal Transduction; Subarachnoid Hemorrhage; Toll-Like Receptor 4; Toll-Like Receptor 9 | 2022 |
Cerebral autoregulation after aneurysmal subarachnoid haemorrhage. A preliminary study comparing dexmedetomidine to propofol and/or midazolam.
Topics: Cerebrovascular Circulation; Dexmedetomidine; Homeostasis; Humans; Midazolam; Propofol; Subarachnoid Hemorrhage | 2020 |
A retrospective observational pilot study on the effects of dexmedetomidine on neurological outcomes after aneurysmal subarachnoid hemorrhage.
Topics: Dexmedetomidine; Humans; Intracranial Aneurysm; Pilot Projects; Retrospective Studies; Subarachnoid Hemorrhage | 2021 |
Association between dexmedetomidine use and neurological outcomes in aneurysmal subarachnoid hemorrhage patients: A retrospective observational study.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Dexmedetomidine; Disability Evaluation; Female; Humans; Hypnotics and Sedatives; Intracranial Aneurysm; Lactates; Logistic Models; Male; Middle Aged; Nervous System Diseases; Neurologic Examination; Retrospective Studies; Subarachnoid Hemorrhage | 2018 |
Effect of Dexmedetomidine on Cerebral Vasospasm and Associated Biomarkers in a Rat Subarachnoid Hemorrhage Model.
Topics: Adrenergic alpha-2 Receptor Agonists; Anatomy, Cross-Sectional; Animals; Basilar Artery; Biomarkers; C-Reactive Protein; Dexmedetomidine; Hypnotics and Sedatives; Interleukin-6; Male; Neurologic Examination; Rats; Rats, Wistar; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2019 |
Dexmedetomidine attenuated early brain injury in rats with subarachnoid haemorrhage by suppressing the inflammatory response: The TLR4/NF-κB pathway and the NLRP3 inflammasome may be involved in the mechanism.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Brain Edema; Brain Injuries; Dexmedetomidine; Inflammasomes; Inflammation; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Signal Transduction; Subarachnoid Hemorrhage; Toll-Like Receptor 4 | 2018 |
Is dexmedetomidine really superior to propofol?
Topics: Cerebral Angiography; Dexmedetomidine; Female; Humans; Male; Propofol; Subarachnoid Hemorrhage | 2015 |
In reply: is dexmedetomidine really superior to propofol?
Topics: Cerebral Angiography; Dexmedetomidine; Female; Humans; Male; Propofol; Subarachnoid Hemorrhage | 2015 |
Dexmedetomidine post-treatment induces neuroprotection via activation of extracellular signal-regulated kinase in rats with subarachnoid haemorrhage.
Topics: Analgesics, Non-Narcotic; Animals; Blood-Brain Barrier; Blotting, Western; Dexmedetomidine; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Male; Neuroprotection; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 2016 |
Re: The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage (Cosar et al. Surg Neurol 2009;71:54-59).
Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Dexmedetomidine; Disease Models, Animal; Hippocampus; Humans; Neuroprotective Agents; Rabbits; Reserpine; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2009 |
The effects of dexmedetomidine dosage on cerebral vasospasm in a rat subarachnoid haemorrhage model.
Topics: Analgesics, Non-Narcotic; Animals; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Pons; Rats; Rats, Wistar; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2010 |
Brain tissue oxygenation during dexmedetomidine administration in surgical patients with neurovascular injuries.
Topics: Adult; Aged; Blood Pressure; Brain Chemistry; Cerebrovascular Disorders; Databases, Factual; Dexmedetomidine; Female; Heart Rate; Humans; Hypnotics and Sedatives; Intracranial Arteriovenous Malformations; Male; Middle Aged; Neurosurgical Procedures; Oxygen Consumption; Retrospective Studies; Subarachnoid Hemorrhage | 2010 |
The neuroprotective effect of dexmedetomidine in the hippocampus of rabbits after subarachnoid hemorrhage.
Topics: Animals; Antioxidants; Dexmedetomidine; Hippocampus; Male; Malondialdehyde; Neuroprotective Agents; Oxidants; Rabbits; Subarachnoid Hemorrhage; Superoxide Dismutase; Vasospasm, Intracranial; Xanthine Oxidase | 2009 |